Issue of 100 (One Hundred) Unsecured Foreign Currency Convertible Bonds of an aggregate principal amount of USD 10,000,000 (Ten Million United States Dollars) at an Issue Price of USD 100,000 (One Hundred Thousand United States Dollars) each at zero coupon and an aggregate yield to maturity of 7% (Seven Per Cent.), with a maturity tenure of 10 (Ten) years and 1 (One) day due October 04, 2034, on private placement basis to Amicorp Capital (Mauritius) Limited. The Company, at its discretion, may issue a further 20 (Twenty) Unsecured Foreign Currency Convertible Bonds of an aggregate amount of USD 2,000,000 (Two Million United States Dollar) ('Green Shoe Option') within 30 (thirty) days from the closing date.

pdf

Fredun Pharmaceuticals Ltd.

01 Oct 2024

699.35

-1.03%

AGM

Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Submission of Voting Results and Scrutinizer Report of 37th Annual General Meeting.

pdf

Fredun Pharmaceuticals Ltd.

30 Sep 2024

699.35

-1.03%

AGM

Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

outcome of the 37th Annual General Meeting of Fredun Pharmaceuticals Limited held on Monday ,30th September, 2024 through video conferencing (VC)/ OVAM.

pdf

Fredun Pharmaceuticals Ltd.

26 Sep 2024

699.35

-1.03%

SAST

Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window

BSE India

The trading window for dealing in securities will remain closed from 27th September, 2024 and will continue to remain close till 48 hours from the declarations of the financial results for the quarter ended 30.09.2024

pdf

Fredun Pharmaceuticals Ltd.

26 Sep 2024

699.35

-1.03%

Board Meeting

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Prior Intimation For The Board Meeting …

BSE India

Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/10/2024 ,inter alia, to consider and approve We wish to inform you that pursuant to Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors (the "Board") of Fredun Pharmaceuticals Limited (the "Company") is scheduled to be held on Thursday, 03rd October, 2024 to inter alia consider issue and allotment of Unsecured Foreign Currency Convertible Bonds (FCCBs), in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013 and any other regulations and rules as applicable, as amended subject to such regulatory/ statutory approvals as may be required.

pdf